How much funding has Earli raised?

Earli has raised $40.0M in total funding, most recently a Series A round.

Who are Earli's investors?

Earli's investors include Khosla Ventures, Andreessen Horowitz.

Where is Earli headquartered?

Earli is headquartered in Redwood City, California, United States.

Earli

Make Cancer A Benign Experience

Redwood City, United States · Founded 2018 · $40.0M raised

Healthcare

Headquarters: Redwood City, California
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: earli.com
Total Funding: $40.0M
Last Round: $40.0M Series AJan 2021
Rounds: 1

About

Earli is a biotechnology company developing programmable genetic constructs that selectively activate inside cancer cells, reprogramming them to produce their own therapies and destroy themselves. Founded in June 2018 by Cyriac Roeding, David Suhy, and Sanjiv Gambhir at Johnson & Johnson JLABS in South San Francisco, the company is pioneering a synthetic biology approach to early cancer detection and treatment. Earli is backed by prominent investors including Andreessen Horowitz and Khosla Ventures and is headquartered in Redwood City, California.

Summary

Earli is a Healthcare company based in Redwood City, United States, founded in 2018. It has raised $40.0M in total across 1 round, most recently a $40.0M Series A round in Jan 2021. Investors include Khosla Ventures and Andreessen Horowitz.

LinkedIn X (Twitter)